157 related articles for article (PubMed ID: 21941847)
1. [Successful plasma exchange treatment for a case with neuromyelitis optica].
Fukui M; Shimakawa S; Ashida A; Takahashi T; Tamai H
No To Hattatsu; 2011 Sep; 43(5):389-93. PubMed ID: 21941847
[TBL] [Abstract][Full Text] [Related]
2. [Elderly onset case of neuromyelitis optica that developed at the age of 90].
Kikumoto M; Nonaka M; Takeshita J; Ohshita T; Yamashita H
Rinsho Shinkeigaku; 2018 Dec; 58(12):761-763. PubMed ID: 30487360
[TBL] [Abstract][Full Text] [Related]
3. Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case.
Miao J; Aboagye DE; Chulpayev B; Liu L; Ishkanian G; Kolanuvada B; Alaie D; Petrillo RL
Am J Case Rep; 2018 Jan; 19():41-46. PubMed ID: 29321467
[TBL] [Abstract][Full Text] [Related]
4. Influenza-associated monophasic neuromyelitis optica.
Nakamura Y; Ikeda K; Yoshii Y; Ito H; Hirayama T; Kawabe K; Kano O; Iwasaki Y
Intern Med; 2011; 50(15):1605-9. PubMed ID: 21804290
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of neuromyelitis optica spectrum disorder by early initiation of plasma exchange].
Koda A; Kaneko S; Asayama S; Fujita K; Kusaka H
Rinsho Shinkeigaku; 2015; 55(1):41-4. PubMed ID: 25672865
[TBL] [Abstract][Full Text] [Related]
6. [Neuromyelitis optica in a patient with Sjögren syndrome with distal renal tubular acidosis: case report].
Imbe H; Nakajima H; Ito T; Kitaoka H
Rinsho Shinkeigaku; 2010 Mar; 50(3):168-71. PubMed ID: 20235486
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.
Watanabe S; Nakashima I; Misu T; Miyazawa I; Shiga Y; Fujihara K; Itoyama Y
Mult Scler; 2007 Jan; 13(1):128-32. PubMed ID: 17294622
[TBL] [Abstract][Full Text] [Related]
8. [Anti-MOG + neuromyelitis optica spectrum disorders treated with plasmapheresis].
Oshiro A; Nakamura S; Tamashiro K; Fujihara K
No To Hattatsu; 2016 May; 48(3):199-203. PubMed ID: 27349083
[TBL] [Abstract][Full Text] [Related]
9. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
Merle H; Olindo S; Jeannin S; Valentino R; Mehdaoui H; Cabot F; Donnio A; Hage R; Richer R; Smadja D; Cabre P
Arch Ophthalmol; 2012 Jul; 130(7):858-62. PubMed ID: 22776923
[TBL] [Abstract][Full Text] [Related]
10. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.
Bonnan M; Valentino R; Debeugny S; Merle H; Fergé JL; Mehdaoui H; Cabre P
J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):346-351. PubMed ID: 29030418
[TBL] [Abstract][Full Text] [Related]
11. [Case of NMO (neuromyelitis optica) spectum disorder triggered by interferon alpha, which involved extensive pyramidal tract lesion of the brain].
Yamasaki M; Matsumoto K; Takahashi Y; Nakanishi H; Kawai Y; Miyamura M
Rinsho Shinkeigaku; 2012; 52(1):19-24. PubMed ID: 22260974
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica (Devic's syndrome).
Wingerchuk DM; Weinshenker BG
Handb Clin Neurol; 2014; 122():581-99. PubMed ID: 24507536
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of NMO].
Saida T
Rinsho Shinkeigaku; 2009 Nov; 49(11):902-5. PubMed ID: 20030244
[TBL] [Abstract][Full Text] [Related]
14. [Topics of neuromyelitis optica].
Miyamoto K
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):468-74. PubMed ID: 25748131
[TBL] [Abstract][Full Text] [Related]
15. [A case of neuromyelitis optica spectrum disorder (NMOSD) with Sjögren's syndrome manifested only brain involvement by preceding parotitis].
Furukawa T; Matsui N; Tanaka K; Izumi Y; Kaji R
Rinsho Shinkeigaku; 2017 Feb; 57(2):77-81. PubMed ID: 28132975
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica.
Guo S; Jiang H; Jiang L; Peng J; Liu H; Wang J; Wei W
Sci Rep; 2021 Nov; 11(1):22229. PubMed ID: 34782653
[TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
[TBL] [Abstract][Full Text] [Related]
18. Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis.
Li H; Wang Y; Xu Q; Zhang A; Zhou H; Zhao S; Kang H; Peng C; Cao S; Wei S
J Neurol; 2015 Oct; 262(10):2293-304. PubMed ID: 26162715
[TBL] [Abstract][Full Text] [Related]
19. [Effects of intravenous methylprednisolone pulse therapy on recurrent optic neuritis associated with aquaporin 4 antibody seropositive neuromyelitis optica].
Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):509-513. PubMed ID: 32842332
[No Abstract] [Full Text] [Related]
20. Anti-aquaporin-4 antibody-positive optic neuritis treated with double-filtration plasmapheresis.
Yoshida H; Ando A; Sho K; Akioka M; Kawai E; Arai E; Nishimura T; Shinde A; Masaki H; Takahashi K; Takagi M; Tanaka K
J Ocul Pharmacol Ther; 2010 Aug; 26(4):381-5. PubMed ID: 20698801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
